Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer
Clinical trial NCT07037199 · RECRUITING
Trial details
- NCT number
- NCT07037199
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2028-06-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.